ArticleFrontiers in endocrinology2026
The relationship between symptoms of adenomyosis and current ultrasonographic diagnostic criteria.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adenomyosis is a uterine disorder defined by presence of endometrial glands and stroma within the myometrium with surrounding myometrial hyperplasia. Research has shown that ultrasound (US) can play a key role in early adenomyosis diagnosis and treatment. The Morphological Uterus Sonographic Assessment (MUSA) recently published standardized criteria for ultrasonographic diagnosis of adenomyosis, but the relationship between these criteria and clinical symptoms, has yet to be clinically validated. Objectives: To assess the prevalence of MUSA ultrasound criteria of adenomyosis and relationship between rates of ultrasound features and clinical symptoms of adenomyosis. Methods: This is an analytical cross-sectional study of patients aged 18-52 receiving a transvaginal ultrasound for any indication at a single outpatient imaging center. Patients were excluded if they had a hysterectomy and/or bilateral oophorectomy, were in menopause, or had active gynecologic malignancy. Patients completed a survey to assess for infertility or fertility-related healthcare use, heavy menstrual bleeding, and pelvic pain. Ultrasound images were assessed by a radiologist using MUSA criteria to evaluate for adenomyosis. Multivariate analyses assessed association between MUSA features and patient-reported symptoms. Results: Of 271 recruited participants, 11.4% had at least one direct feature of adenomyosis, 57.6% had no direct features but at least one indirect feature, and 31.0% had no features. After controlling for potential confounders in multivariable analysis, patients with direct features resulted in 5.955-point higher heavy bleeding scores compared to those with no features (95% CI 1.970-9.939, p=0.004). When controlling for covariates, the association between indirect features and adenomyosis symptoms were not significant. Subjects with middle myometrium invasion reported increased rates of infertility (p=0.006), whereas subjects with outer myometrial involvement reported significantly higher heavy bleeding (p=0.002). Conclusions: Per MUSA criteria, 1 in 10 participants displayed ultrasonographic findings strongly suggestive of presence of adenomyosis. Patients with direct features were more likely to experience heavy menstrual bleeding. Layer of uterine involvement were found to have greater association with infertility and pelvic pain than any one MUSA feature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.